Animal Models of Anemia

Inotiv, Inc. Announces Expansion of Pharmacology and Pathology Offerings with Agreement to Purchase Bolder BioPATH, Inc.

04-16-21

WEST LAFAYETTE, Ind., April 16, 2021 (GLOBE NEWSWIRE) — Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading provider of non-clinical and analytical contract research services, today announced that the Company has entered into an agreement and plan of merger with Bolder BioPATH, Inc. (“Bolder BioPATH”), a contract pharmacology and pathology company specializing […]

We are eager to help you continue your drug development & discovery programs

03-27-20

In these trying time, we know the importance of having suppliers that you can count on. We have implemented advanced cleaning schedules, flexible work hours and enhanced employee screening, to ensure that our operations can continue uninterrupted. Please reach out to us if we can be of service.

Bolder BioPath

Models We Conduct

Anemia

Tell Us About Your Project! Get a Quote »

Inotiv, Inc. Announces Expansion of Pharmacology and Pathology Offerings with Agreement to Purchase Bolder BioPATH, Inc.

We are eager to help you continue your drug development & discovery programs

Covid-19 Response as Operations Continue

Please come join us at the Keystone Symposia on Tissue Immunity (Jan 26-29, 2020 in Boulder, CO)

Exciting Changes Coming in 2020!

A Novel ROR-Gamma Inhibitor (VPR-254) Attenuates Key Parameters of Innate Immune Colitis in Mice

AAALAC Accreditation

OARSI 2017 World Congress on Osteoarthritis